IGF2BP3 and fragile X-associated tremor/ataxia syndrome: Additionally, decreasing IGF2BP3 in both neuronal and animal models rescued FXPAC-like phenotypes, suggesting that IGF2BP3 can be a potential therapeutic target in FXTAS.